September 2, 2025

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A Healthcare Contender with 53.10% Revenue Growth

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is making waves in the healthcare sector as a dynamic player within the Drug Manufacturers – Specialty & Generic industry. With a robust market capitalization..

Evolent Health, Inc. (EVH) Stock Analysis: Exploring a 60.22% Potential Upside in Healthcare Innovation

Evolent Health, Inc. (NYSE: EVH), a key player in the healthcare sector, is garnering significant attention from investors due to its innovative approach in health information services and its intriguing..

GRAIL, Inc. (GRAL) Stock Analysis: A Healthcare Innovator with a 23.51% Upside Potential

GRAIL, Inc. (GRAL), a dynamic player in the healthcare sector, is making waves with its innovative approach to cancer diagnostics and research. Headquartered in Menlo Park, California, GRAIL specializes in..

Kestra Medical Technologies (KMTS): A 66% Potential Upside Amidst Rapid Revenue Growth

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a trailblazer in the healthcare sector specializing in medical instruments and supplies, is garnering attention from investors with its substantial growth potential. This U.S.-based..

agilon health, inc. (AGL) Stock Analysis: Unpacking the 21% Potential Upside in Healthcare Investment

agilon health, inc. (NYSE: AGL) operates in the dynamic healthcare sector, specifically within the medical care facilities industry. With its focus on providing comprehensive healthcare services to seniors through primary..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a Potential 125% Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a dynamic player in the healthcare sector, is turning heads with a potential upside of 125.30% according to analyst ratings. With a market capitalization of..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 100% Upside Potential in Biotechnology

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is currently making waves among investors with its compelling growth potential and strategic collaborations. Headquartered in Burlingame, California, Innoviva..

Immunocore Holdings plc (IMCR) Stock Analysis: A Biotech with a 93% Potential Upside

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology firm, is garnering significant attention from investors due to its promising portfolio of immunotherapies and an impressive potential upside of 93.03%. Specializing..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 162% Potential Upside Amidst Market Challenges

Opko Health, Inc. (NASDAQ: OPK) is a prominent player within the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization of $1.1 billion, Opko Health operates..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Uncovering a 28.89% Potential Upside

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, has attracted significant investor interest due to its promising growth metrics and robust market presence. Specializing in..

89bio, Inc. (ETNB) Stock Analysis: Exploring a 232% Potential Upside in Biotechnology

89bio, Inc. (NASDAQ: ETNB) is making waves in the biotechnology sector with its promising pipeline and compelling financial metrics. This clinical-stage biopharmaceutical company, headquartered in San Francisco, is focused on..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Biotech with a 169% Upside Potential

Apogee Therapeutics, Inc. (APGE) is capturing the attention of the biotechnology investment community with its promising pipeline and potential for significant stock appreciation. As a clinical-stage biotech company, Apogee focuses..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Harnessing a Potential 166% Upside with Innovative Allergy Solutions

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) is captivating investor attention with its innovative approach in the biotechnology space, specifically targeting the treatment of severe allergic reactions. Operating within the healthcare sector,..

Investor Outlook: Arcutis Biotherapeutics (ARQT) Poised for 40% Upside Potential Amid Strong Analyst Consensus

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a promising player in the biotechnology sector, is making waves with its focused approach to developing innovative treatments for dermatological diseases. With a market capitalization..

Biohaven Ltd. (BHVN) Stock Analysis: Unveiling a 206.32% Potential Upside in the Biotech Sector

Biohaven Ltd. (BHVN), a burgeoning player in the biotechnology sector, is capturing investor attention with its ambitious pipeline and impressive analyst ratings. With a market capitalization of $1.63 billion, Biohaven..

Arrowhead Pharmaceuticals (ARWR): Analyst Consensus and 98.75% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, has captured investor interest with a compelling growth narrative and a promising pipeline of advanced therapeutic candidates. With..

HUTCHMED (China) Limited (HCM) Stock Analysis: Navigating a 52% Potential Upside Amidst Healthcare Innovations

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector specializing in the development of targeted therapeutics and immunotherapies, offers a compelling case for investors interested in the..

PACS Group, Inc. (PACS) Stock Analysis: Exploring a Potential 162% Upside in the Healthcare Sector

PACS Group, Inc. (PACS), a notable player in the healthcare sector, is currently capturing the attention of investors with its substantial potential upside. Operating primarily in the medical care facilities..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 35.19% Upside Potential in the Biotech Arena

PTC Therapeutics, Inc. (NASDAQ: PTCT) is a compelling player in the biotechnology sector, offering significant upside potential for investors willing to navigate the complexities of the biopharmaceutical landscape. As a..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 39.93% Potential Upside with Strong Buy Ratings

Schrodinger, Inc. (SDGR) stands out in the healthcare sector as a pioneer in health information services, leveraging cutting-edge technology to advance molecular discovery. Headquartered in New York, this innovative company..

Search

Funds

September 2, 2025

Search

Funds

September 2, 2025

FTSE 100

Funds